lauric acid has been researched along with Adenoma, Prostatic in 3 studies
dodecanoic acid : A straight-chain, twelve-carbon medium-chain saturated fatty acid with strong bactericidal properties; the main fatty acid in coconut oil and palm kernel oil.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The treatment of benign prostatic hyperplasia can be accomplished by the use of different drugs including, doxazosin, an α-1 adrenergic antagonist, and finasteride (FIN), a 5-α reductase inhibitor." | 7.79 | Development of a doxazosin and finasteride transdermal system for combination therapy of benign prostatic hyperplasia. ( Abrahim-Vieira, B; Cabral, LM; De Sousa, VP; Do Carmo, FA; Lopes, M; Padula, C; Pupe, CG; Ribeiro, AJ; Rodrigues, CR; Santi, P; Veiga, F, 2013) |
| "Lauric acid/myristic acid treatment showed significant inhibition of prostate enlargement and protection of histoarchitecture of prostate when compared with positive control group." | 5.36 | Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats. ( Patil, AA; Veeresh Babu, SV; Veeresh, B; Warke, YB, 2010) |
| "The treatment of benign prostatic hyperplasia can be accomplished by the use of different drugs including, doxazosin, an α-1 adrenergic antagonist, and finasteride (FIN), a 5-α reductase inhibitor." | 3.79 | Development of a doxazosin and finasteride transdermal system for combination therapy of benign prostatic hyperplasia. ( Abrahim-Vieira, B; Cabral, LM; De Sousa, VP; Do Carmo, FA; Lopes, M; Padula, C; Pupe, CG; Ribeiro, AJ; Rodrigues, CR; Santi, P; Veiga, F, 2013) |
| "Lauric acid/myristic acid treatment showed significant inhibition of prostate enlargement and protection of histoarchitecture of prostate when compared with positive control group." | 1.36 | Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats. ( Patil, AA; Veeresh Babu, SV; Veeresh, B; Warke, YB, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pupe, CG | 1 |
| Do Carmo, FA | 1 |
| De Sousa, VP | 1 |
| Lopes, M | 1 |
| Abrahim-Vieira, B | 1 |
| Ribeiro, AJ | 1 |
| Veiga, F | 1 |
| Rodrigues, CR | 1 |
| Padula, C | 1 |
| Santi, P | 1 |
| Cabral, LM | 1 |
| Veeresh Babu, SV | 1 |
| Veeresh, B | 1 |
| Patil, AA | 1 |
| Warke, YB | 1 |
| Arruzazabala, ML | 1 |
| Pérez, Y | 1 |
| Ravelo, Y | 1 |
| Molina, V | 1 |
| Carbajal, D | 1 |
| Mas, R | 1 |
| Rodríguez, E | 1 |
3 other studies available for lauric acid and Adenoma, Prostatic
| Article | Year |
|---|---|
Development of a doxazosin and finasteride transdermal system for combination therapy of benign prostatic hyperplasia.
Topics: 5-alpha Reductase Inhibitors; Administration, Cutaneous; Adrenergic alpha-1 Receptor Antagonists; An | 2013 |
Lauric acid and myristic acid prevent testosterone induced prostatic hyperplasia in rats.
Topics: Administration, Oral; Animals; Body Weight; Lauric Acids; Male; Myristic Acid; Organ Size; Prostate; | 2010 |
Effect of oleic, lauric and myristic acids on phenylephrine-induced contractions of isolated rat vas deferens.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Arecaceae; In Vitro Techniques; Lauric Acids; Male | 2011 |